APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncology (Anti-cancer Drugs)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oncology (Anti-cancer Drugs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchOncology (Anti-cancer Drugs) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncology (Anti-cancer Drugs) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Oncology (Anti-cancer Drugs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncology (Anti-cancer Drugs) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncology (Anti-cancer Drugs) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oncology (Anti-cancer Drugs) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oncology (Anti-cancer Drugs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oncology (Anti-cancer Drugs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oncology (Anti-cancer Drugs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oncology (Anti-cancer Drugs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oncology (Anti-cancer Drugs) include Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Eli lilly, Pfizer, GlaxoSmithKline and Amgen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oncology (Anti-cancer Drugs) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oncology (Anti-cancer Drugs) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oncology (Anti-cancer Drugs) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oncology (Anti-cancer Drugs) market size, projected growth trends, production technologies, key applications, and end-use industries.

Oncology (Anti-cancer Drugs) Segment by Company

Sanofi

Johnson & Johnson

Novartis

Merck

Roche

Eli lilly

Pfizer

GlaxoSmithKline

Amgen

Celgene

Oncology (Anti-cancer Drugs) Segment by Type

Blood Cancer

Gastrointestinal Cancer

Breast Cancer

Prostate Cancer

Others

Oncology (Anti-cancer Drugs) Segment by Application

Immunotherapy (Biologic Therapy)

Hormonal Therapy

Chemotherapy

Targeted Therapy

Others

Oncology (Anti-cancer Drugs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology (Anti-cancer Drugs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncology (Anti-cancer Drugs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology (Anti-cancer Drugs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oncology (Anti-cancer Drugs) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oncology (Anti-cancer Drugs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oncology (Anti-cancer Drugs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oncology (Anti-cancer Drugs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oncology (Anti-cancer Drugs) Industry Trends Table 2. Oncology (Anti-cancer Drugs) Industry Drivers Table 3. Oncology (Anti-cancer Drugs) Industry Opportunities and Challenges Table 4. Oncology (Anti-cancer Drugs) Industry Restraints Table 5. Global Oncology (Anti-cancer Drugs) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oncology (Anti-cancer Drugs) Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global Oncology (Anti-cancer Drugs) Sales Market Share by Manufacturers Table 9. Global Oncology (Anti-cancer Drugs) Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global Oncology (Anti-cancer Drugs) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oncology (Anti-cancer Drugs) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oncology (Anti-cancer Drugs) Manufacturers, Product Type & Application Table 13. Global Oncology (Anti-cancer Drugs) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oncology (Anti-cancer Drugs) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Blood Cancer Table 17. Major Manufacturers of Gastrointestinal Cancer Table 18. Major Manufacturers of Breast Cancer Table 19. Major Manufacturers of Prostate Cancer Table 20. Major Manufacturers of Others Table 21. Global Oncology (Anti-cancer Drugs) Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 22. Global Oncology (Anti-cancer Drugs) Sales by Type (2021-2026) & (k tons) Table 23. Global Oncology (Anti-cancer Drugs) Sales by Type (2027-2032) & (k tons) Table 24. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2021-2026) Table 25. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2027-2032) Table 26. Global Oncology (Anti-cancer Drugs) Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 27. Global Oncology (Anti-cancer Drugs) Revenue by Type (2021-2026) & (k tons) Table 28. Global Oncology (Anti-cancer Drugs) Revenue by Type (2027-2032) & (k tons) Table 29. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2021-2026) Table 30. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Immunotherapy (Biologic Therapy) Table 32. Major Manufacturers of Hormonal Therapy Table 33. Major Manufacturers of Chemotherapy Table 34. Major Manufacturers of Targeted Therapy Table 35. Major Manufacturers of Others Table 36. Global Oncology (Anti-cancer Drugs) Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 37. Global Oncology (Anti-cancer Drugs) Sales by Application (2021-2026) & (k tons) Table 38. Global Oncology (Anti-cancer Drugs) Sales by Application (2027-2032) & (k tons) Table 39. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2021-2026) Table 40. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2027-2032) Table 41. Global Oncology (Anti-cancer Drugs) Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 42. Global Oncology (Anti-cancer Drugs) Revenue by Application (2021-2026) & (k tons) Table 43. Global Oncology (Anti-cancer Drugs) Revenue by Application (2027-2032) & (k tons) Table 44. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2021-2026) Table 45. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2027-2032) Table 46. Global Oncology (Anti-cancer Drugs) Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 47. Global Oncology (Anti-cancer Drugs) Sales by Region (2021-2026) & (k tons) Table 48. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2021-2026) Table 49. Global Oncology (Anti-cancer Drugs) Sales Forecasted by Region (2027-2032) & (k tons) Table 50. Global Oncology (Anti-cancer Drugs) Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Oncology (Anti-cancer Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 52. North America Oncology (Anti-cancer Drugs) Sales by Country (2021-2026) & (k tons) Table 53. North America Oncology (Anti-cancer Drugs) Sales by Country (2027-2032) & (k tons) Table 54. Europe Oncology (Anti-cancer Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 55. Europe Oncology (Anti-cancer Drugs) Sales by Country (2021-2026) & (k tons) Table 56. Europe Oncology (Anti-cancer Drugs) Sales by Country (2027-2032) & (k tons) Table 57. Asia Pacific Oncology (Anti-cancer Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 58. Asia Pacific Oncology (Anti-cancer Drugs) Sales by Country (2021-2026) & (k tons) Table 59. Asia Pacific Oncology (Anti-cancer Drugs) Sales by Country (2027-2032) & (k tons) Table 60. South America, Middle East and Africa Oncology (Anti-cancer Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 61. South America, Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2021-2026) & (k tons) Table 62. South America, Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2027-2032) & (k tons) Table 63. Global Oncology (Anti-cancer Drugs) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Oncology (Anti-cancer Drugs) Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Oncology (Anti-cancer Drugs) Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2021-2026) Table 67. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2027-2032) Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Oncology (Anti-cancer Drugs) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sanofi Oncology (Anti-cancer Drugs) Product Portfolio Table 72. Sanofi Recent Development Table 73. Johnson & Johnson Company Information Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson Oncology (Anti-cancer Drugs) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Johnson & Johnson Oncology (Anti-cancer Drugs) Product Portfolio Table 77. Johnson & Johnson Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Oncology (Anti-cancer Drugs) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Novartis Oncology (Anti-cancer Drugs) Product Portfolio Table 82. Novartis Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Oncology (Anti-cancer Drugs) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Merck Oncology (Anti-cancer Drugs) Product Portfolio Table 87. Merck Recent Development Table 88. Roche Company Information Table 89. Roche Business Overview Table 90. Roche Oncology (Anti-cancer Drugs) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Roche Oncology (Anti-cancer Drugs) Product Portfolio Table 92. Roche Recent Development Table 93. Eli lilly Company Information Table 94. Eli lilly Business Overview Table 95. Eli lilly Oncology (Anti-cancer Drugs) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Eli lilly Oncology (Anti-cancer Drugs) Product Portfolio Table 97. Eli lilly Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Oncology (Anti-cancer Drugs) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Pfizer Oncology (Anti-cancer Drugs) Product Portfolio Table 102. Pfizer Recent Development Table 103. GlaxoSmithKline Company Information Table 104. GlaxoSmithKline Business Overview Table 105. GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Portfolio Table 107. GlaxoSmithKline Recent Development Table 108. Amgen Company Information Table 109. Amgen Business Overview Table 110. Amgen Oncology (Anti-cancer Drugs) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Amgen Oncology (Anti-cancer Drugs) Product Portfolio Table 112. Amgen Recent Development Table 113. Celgene Company Information Table 114. Celgene Business Overview Table 115. Celgene Oncology (Anti-cancer Drugs) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Celgene Oncology (Anti-cancer Drugs) Product Portfolio Table 117. Celgene Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Oncology (Anti-cancer Drugs) Distributors List Table 121. Oncology (Anti-cancer Drugs) Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Oncology (Anti-cancer Drugs) Product Image Figure 2. Global Oncology (Anti-cancer Drugs) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oncology (Anti-cancer Drugs) Market Size (2021-2032) & (US$ Million) Figure 4. Global Oncology (Anti-cancer Drugs) Sales (2021-2032) & (k tons) Figure 5. Global Oncology (Anti-cancer Drugs) Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 Oncology (Anti-cancer Drugs) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Blood Cancer Image Figure 9. Gastrointestinal Cancer Image Figure 10. Breast Cancer Image Figure 11. Prostate Cancer Image Figure 12. Others Image Figure 13. Global Oncology (Anti-cancer Drugs) Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 14. Global Oncology (Anti-cancer Drugs) Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2021-2032) Figure 16. Global Oncology (Anti-cancer Drugs) Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 17. Global Oncology (Anti-cancer Drugs) Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2021-2032) Figure 19. Immunotherapy (Biologic Therapy) Image Figure 20. Hormonal Therapy Image Figure 21. Chemotherapy Image Figure 22. Targeted Therapy Image Figure 23. Others Image Figure 24. Global Oncology (Anti-cancer Drugs) Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 25. Global Oncology (Anti-cancer Drugs) Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2021-2032) Figure 27. Global Oncology (Anti-cancer Drugs) Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 28. Global Oncology (Anti-cancer Drugs) Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2021-2032) Figure 30. North America Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 31. North America Oncology (Anti-cancer Drugs) Sales Market Share by Country (2021-2032) Figure 32. U.S. Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 33. Canada Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 34. Mexico Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 35. Europe Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 36. Europe Oncology (Anti-cancer Drugs) Sales Market Share by Country (2021-2032) Figure 37. Germany Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 38. France Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 39. U.K. Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 40. Italy Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 41. Netherlands Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 42. Asia Pacific Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 43. Asia Pacific Oncology (Anti-cancer Drugs) Sales Market Share by Country (2021-2032) Figure 44. China Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 45. Japan Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 46. South Korea Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 47. Southeast Asia Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 48. India Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 49. Australia Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 50. South America, Middle East and Africa Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 51. South America, Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share by Country (2021-2032) Figure 52. Brazil Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 53. South Africa Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 54. Saudi Arabia Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 55. Turkey Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 56. Argentina Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 57. UAE Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 58. Egypt Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 59. Chile Oncology (Anti-cancer Drugs) Sales and Growth Rate (2021-2032) & (k tons) Figure 60. Global Oncology (Anti-cancer Drugs) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Figure 63. North America Oncology (Anti-cancer Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Figure 65. Europe Oncology (Anti-cancer Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Oncology (Anti-cancer Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Oncology (Anti-cancer Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Oncology (Anti-cancer Drugs) Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Oncology (Anti-cancer Drugs) Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Cancer
  • Gastrointestinal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Others
Applications
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Chemotherapy
  • Targeted Therapy
  • Others
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Roche
  • Eli lilly
  • Pfizer
  • GlaxoSmithKline
  • Amgen
  • Celgene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oncology (Anti-cancer Drugs) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oncology (Anti-cancer Drugs) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oncology (Anti-cancer Drugs) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oncology (Anti-cancer Drugs) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oncology (Anti-cancer Drugs) Market Dynamics
  1. 2.1 Oncology (Anti-cancer Drugs) Industry Trends
  2. 2.2 Oncology (Anti-cancer Drugs) Industry Drivers
  3. 2.3 Oncology (Anti-cancer Drugs) Industry Opportunities and Challenges
  4. 2.4 Oncology (Anti-cancer Drugs) Industry Restraints
3 Oncology (Anti-cancer Drugs) Market by Manufacturers
  1. 3.1 Global Oncology (Anti-cancer Drugs) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oncology (Anti-cancer Drugs) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oncology (Anti-cancer Drugs) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oncology (Anti-cancer Drugs) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oncology (Anti-cancer Drugs) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oncology (Anti-cancer Drugs) Manufacturers, Product Type & Application
  7. 3.7 Global Oncology (Anti-cancer Drugs) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oncology (Anti-cancer Drugs) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oncology (Anti-cancer Drugs) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oncology (Anti-cancer Drugs) Tier 1, Tier 2, and Tier 3
4 Oncology (Anti-cancer Drugs) Market by Type
  1. 4.1 Oncology (Anti-cancer Drugs) Type Introduction
  2. 4.1.1 Blood Cancer
  3. 4.1.2 Gastrointestinal Cancer
  4. 4.1.3 Breast Cancer
  5. 4.1.4 Prostate Cancer
  6. 4.1.5 Others
  7. 4.2 Global Oncology (Anti-cancer Drugs) Sales by Type
  8. 4.2.1 Global Oncology (Anti-cancer Drugs) Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Oncology (Anti-cancer Drugs) Sales by Type (2021-2032)
  10. 4.2.3 Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2021-2032)
  11. 4.3 Global Oncology (Anti-cancer Drugs) Revenue by Type
  12. 4.3.1 Global Oncology (Anti-cancer Drugs) Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Oncology (Anti-cancer Drugs) Revenue by Type (2021-2032)
  14. 4.3.3 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2021-2032)
5 Oncology (Anti-cancer Drugs) Market by Application
  1. 5.1 Oncology (Anti-cancer Drugs) Application Introduction
  2. 5.1.1 Immunotherapy (Biologic Therapy)
  3. 5.1.2 Hormonal Therapy
  4. 5.1.3 Chemotherapy
  5. 5.1.4 Targeted Therapy
  6. 5.1.5 Others
  7. 5.2 Global Oncology (Anti-cancer Drugs) Sales by Application
  8. 5.2.1 Global Oncology (Anti-cancer Drugs) Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Oncology (Anti-cancer Drugs) Sales by Application (2021-2032)
  10. 5.2.3 Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2021-2032)
  11. 5.3 Global Oncology (Anti-cancer Drugs) Revenue by Application
  12. 5.3.1 Global Oncology (Anti-cancer Drugs) Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Oncology (Anti-cancer Drugs) Revenue by Application (2021-2032)
  14. 5.3.3 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2021-2032)
6 Global Oncology (Anti-cancer Drugs) Sales by Region
  1. 6.1 Global Oncology (Anti-cancer Drugs) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oncology (Anti-cancer Drugs) Sales by Region (2021-2032)
  3. 6.2.1 Global Oncology (Anti-cancer Drugs) Sales by Region (2021-2026)
  4. 6.2.2 Global Oncology (Anti-cancer Drugs) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oncology (Anti-cancer Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oncology (Anti-cancer Drugs) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oncology (Anti-cancer Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oncology (Anti-cancer Drugs) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oncology (Anti-cancer Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oncology (Anti-cancer Drugs) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oncology (Anti-cancer Drugs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oncology (Anti-cancer Drugs) Revenue by Region
  1. 7.1 Global Oncology (Anti-cancer Drugs) Revenue by Region
  2. 7.1.1 Global Oncology (Anti-cancer Drugs) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oncology (Anti-cancer Drugs) Revenue by Region (2021-2026)
  4. 7.1.3 Global Oncology (Anti-cancer Drugs) Revenue by Region (2027-2032)
  5. 7.1.4 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oncology (Anti-cancer Drugs) Revenue (2021-2032)
  8. 7.2.2 North America Oncology (Anti-cancer Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oncology (Anti-cancer Drugs) Revenue (2021-2032)
  11. 7.3.2 Europe Oncology (Anti-cancer Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oncology (Anti-cancer Drugs) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oncology (Anti-cancer Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oncology (Anti-cancer Drugs) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oncology (Anti-cancer Drugs) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Oncology (Anti-cancer Drugs) Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Oncology (Anti-cancer Drugs) Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Oncology (Anti-cancer Drugs) Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Oncology (Anti-cancer Drugs) Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Oncology (Anti-cancer Drugs) Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Eli lilly
  32. 8.6.1 Eli lilly Company Information
  33. 8.6.2 Eli lilly Business Overview
  34. 8.6.3 Eli lilly Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli lilly Oncology (Anti-cancer Drugs) Product Portfolio
  36. 8.6.5 Eli lilly Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Oncology (Anti-cancer Drugs) Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 GlaxoSmithKline
  44. 8.8.1 GlaxoSmithKline Company Information
  45. 8.8.2 GlaxoSmithKline Business Overview
  46. 8.8.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Portfolio
  48. 8.8.5 GlaxoSmithKline Recent Developments
  49. 8.9 Amgen
  50. 8.9.1 Amgen Company Information
  51. 8.9.2 Amgen Business Overview
  52. 8.9.3 Amgen Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Amgen Oncology (Anti-cancer Drugs) Product Portfolio
  54. 8.9.5 Amgen Recent Developments
  55. 8.10 Celgene
  56. 8.10.1 Celgene Company Information
  57. 8.10.2 Celgene Business Overview
  58. 8.10.3 Celgene Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Celgene Oncology (Anti-cancer Drugs) Product Portfolio
  60. 8.10.5 Celgene Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oncology (Anti-cancer Drugs) Value Chain Analysis
  2. 9.1.1 Oncology (Anti-cancer Drugs) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oncology (Anti-cancer Drugs) Production Mode & Process
  6. 9.2 Oncology (Anti-cancer Drugs) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oncology (Anti-cancer Drugs) Distributors
  9. 9.2.3 Oncology (Anti-cancer Drugs) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst